Andre Obenaus1, Amandine Jullienne1, Brenda Patricia Noarbe1, Ashley A Keiser2, Michelle Vy Trinh1, Eniko Kramar2, Joy Beardwood2, Tri Dong2, Marcelo Wood2, and MODEL AD3
1Pediatrics, University of California, Irvine, Irvine, CA, United States, 2Neurobiology and Behavior, University of California, Irvine, Irvine, CA, United States, 3University of California, Irvine, Irvine, CA, United States
Synopsis
Mouse models of
Alzheimer’s disease (AD)
currently do not recapitulate accurately the human disease. The MODEL-AD consortium
has recently developed new mouse models of AD, including the human amyloid β knockin
(hAβKI) mouse. Using high resolution diffusion MRI (dMRI) we examined regional
changes in the hAβKI male and female mouse across its lifespan (4-18mo). Sex
and regional differences were apparent with age, including reduced diffusion
metrics in the hippocampus, that mirrored altered learning and memory.
Preclinical MR phenotyping allows for cross-species comparisons for biomarker
identification.
Introduction
The Model Organism Development and Evaluation for
Late-Onset Alzheimer’s Disease (MODEL-AD) Consortium was established to develop
the next generation of Alzheimer’s disease (AD) models based on human genomic
and imaging data. Recently, MODEL-AD has generated a new human Aβ Knock-In (hAβKI) mouse that substitutes
3-amino acids in the mouse Aβ locus with that of the human amyloid precursor
protein (App) gene (Baglietto-Vargas et al., 2021). This substitution leads to
age-dependent cognitive and synaptic impairments as these mice progressively
age. Neuroimaging of AD is a critical component of human diagnoses and preclinical
magnetic resonance imaging (MRI) can investigate phenotypic alterations in
these new mice models. Specifically, we used diffusion MRI (dMRI) to
investigate brain-wide structural alterations in conjunction with connectomic
analyses in the hAβKI mouse across its lifespan.Methods
We
examined hippocampal synaptic plasticity in slices from male and female hAβKI mice
at 4, 12 and 18mo of age (n=5/group/sex/genotype). For imaging a total of 105 male and
female hAβKI mice at the same time points (WT n=51, hAβKI n=54; ~n=8/sex/time
point). All imaging was performed on a 9.4T (Bruker Biospin, PV5.1) MR scanner.
The following sequences were utilized: 1) diffusion tensor imaging (DTI): 5 B0,
30 directions b=0, 3000 mm2/sec, 25 slices 0.5mm thick for full
brain coverage, 2) multiecho T2 for quantitative relaxation, 3) 3D T2 RARE for
volumetric assessments and 4) susceptibility weighted imaging for iron
deposition. Our automated pipeline for regional analyses utilized the Australian
Mouse Brain Mapping Consortium (AMBMC) atlas which we split for bilateral
measurements. DTI metrics (axial (AxD), radial (RD), mean (MD) diffusivities
and fractional anisotropic (FA) maps) data were extracted from 42 bilateral
regions encompassing cortical, subcortical and white matter regions. Tractography
and connectomics were derived using DSI studio.Results
Impairments in hippocampal
long-term (LTP) were observed in male hAβKI mice at 4 months of age relative to
WT with no significant change observed in females. In female hAβKI mice,
impairments in LTP were observed at 12 and 18 months of age relative to WT with
no significant change observed in males (Fig. 1A). Brain volumes were
significantly decreased in male hAβKI compared to WT mice, but no changes were
found in female hAβKI mice. Volumetric
increases in select brain regions, such as the anterior cingulate cortex in
male hAβKI mice compared to WT were observed but was not related to tissue
relaxation (T2) (Fig. 1). dMRI heatmaps of MD highlighted regional differences
between males and females across time and genotype, with MD progressively
decreasing with time (Fig. 2). Statistical analyses for regional changes showed
that male hAβKI mice had progressive changes within the brain with advancing age
whereas the largest dMRI changes in females was at 12mo of age (Fig. 3). For
example, AxD in 18mo male hAβKI mice was increased in 4 of 7 white matter
regions but not in female hAβKI mice compared to WT. This would suggest
regional and temporal sensitivity to diffusion metrics in the hAβKI mouse
brain. As these animals exhibit impaired hippocampal long-term potentiation, we
probed the CA1 region for diffusion abnormalities. Compared to male WT mice, we found decreased
RD and MD but no change in AxD whereas FA was increased within the CA1 region of
the hippocampus of male hAβKI mice (no change in female mice). Ongoing multishell
dMRI analyses will report neurite and cellular density measures from NODDI
modeling. Discussion
Human AD is a
complex, progressive and multi-faceted disease process in late-onset AD (LOAD) patients.
At the present time there are no animal models that recapitulate all the known
features in LOAD patients. The MODEL-AD consortium has been tasked to develop
better LOAD mouse models. One such recently developed model is the hAβKI mouse.
In male hAβKI mice dMRI metrics, particularly RD and MD (along with FA)
appeared to be sensitive to identify ongoing histopathological perturbations.
The hippocampus of male hAβKI mice but not females, showed reduced diffusion (RD,
MD) consistent with altered tissue structure. White matter was also similarly
affected but to an even larger extent. These findings complement our
observations of impaired hippocampus-dependent memory and LTP in hAβKI mice.Conclusion
Preclinical MRI
can be used to phenotype new mouse models of AD. Using a newly developed mouse
model of AD, the hAβKI mouse, we identified progressive altered regional tissue
metrics. The hippocampal CA1 region in the hAβKI mouse appeared to be
particularly vulnerable, findings consistent with observed impairments in confirmed
LTP and behavioral findings. MRI imaging of new mouse models is a powerful tool
to investigate tissue level modifications to brain structure and function. Comparison of MRI from mouse models of AD and
those from human MRI acquisitions provides the opportunity to compare and
contrast species for evaluation of potential imaging biomarkers. Acknowledgements
MODEL-AD was
established with funding from The National Institute on Aging (U54 AG054345-01,
U54 AG054349-01).References
Baglietto-Vargas,
D., Forner, S., Cai, L. et al. Generation of a humanized Aβ expressing mouse
demonstrating aspects of Alzheimer’s disease-like pathology. Nat Commun 12,
2421 (2021). https://doi.org/10.1038/s41467-021-22624-z